Lataa...
IL-6 modulation for COVID-19: the right patients at the right time?
The ongoing pandemic caused by the novel coronavirus SARS-CoV-2 has disrupted the global economy and strained healthcare systems to their limits. After the virus first emerged in late 2019, the first intervention that demonstrated significant reductions in mortality for severe COVID-19 in large-scal...
Tallennettuna:
| Julkaisussa: | J Immunother Cancer |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8042594/ https://ncbi.nlm.nih.gov/pubmed/33837054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002285 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|